Acute pulmonary edema, capillaritis and alveolar hemorrhage: Pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus?

Lupus

Volumn 14, Issue 7, 2005, Pages 557-560

  Nguyen, Van Anh ^a   Gotwald, T ^a   Prior, C ^b   Obermoser, G ^a   Sepp, N ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alveolar hemorrhage; Antiphospholipid syndrome; Pulmonary capillaritis; Pulmonary radiologic features; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; AZATHIOPRINE; GLUCOCORTICOID; HEPARIN; METHYLPREDNISOLONE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CAPILLARITIS; CASE REPORT; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS HEMORRHAGE; LUNG BIOPSY; LUNG CAPILLARITIS; LUNG EDEMA; LUNG EMBOLISM; LUNG HEMORRHAGE; LUPUS PNEUMONITIS; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY;

ACUTE DISEASE; ADULT; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOPTYSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PULMONARY EDEMA; VASCULITIS;

EID: 23844447960     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2107cr     Document Type: Article

References (17)

1. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on prelimenary classification criteria of definite antiphospholipid syndrome. Arthritis Rheu 1999; 42: 1309-1311.
2. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
3. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990; 112: 682-698.
4. Asherson RA, Cervera R. Review: antiphospholipid antibodies and the lung. J Rheumatol 1995; 22: 62-66.
5. Asherson RA. The catastrophic antiphospholipid syndrome: a review of the clinical features, possible pathogenesis and treatment. Lupus 1998; 7: S55-S62.
6. Gilkeson RC, Patz EF Jr, Culhane D, McAdams HP, Provenzale JM. Thoracic imaging features of patients with antiphospholipid antibodies. J Comput Assist Tomogr 1998; 22: 241-244.
7. Crausman RS, Achenbach GA, Pluss WT, O'Brien RF, Jennings CA. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 1995; 22: 554-556.
8. Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol 1999; 26: 805-807.
9. Primack SL, Miller RR, Müller NL. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. Am J Radiol 1995; 164: 295-300.
10. Müller NL, Miller RR. Diffuse pulmonary hemorrhage. Radiol Clin North Am 1991; 29: 965-971.
11. Segal AM, Calabrese IH, Ahmed M, Tubbs RR, White CS. The pulmonary manifestations of systemic lupus erythematosus. Semin Arthritis Rheum 1985; 14: 202-204.
12. Matthay RA, Schwarz MI, Petty TL et al. Pulmonary manifestations of systemic lupus erythematosus: Review of twelve cases of acute lupus pneumonitis. Medicine 1975; 54: 397-409.
13. Lie JT. Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 1989; 16: 713-715.
14. Del Papa N, Guidali L, Sala A et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 551-561.
15. Green RJ, Ruoss SJ, Kraft SA, Berry GJ, Raffin TA. Pulmonary capillaritis and alveolar hemorrhage: update on diagnosis and management. Chest 1996; 110: 1305-1316.
16. Petri M. Treatment of the antiphospholipid antibody syndrome: progress in the last five years? Curr Rheumatol Rep 2000; 2: 256-261.
17. Douketis JD, Crowther MA, Julian JA et al. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus. Thromb Haemost 1999; 82: 1028-1032.